News FDA approves J&J's prostate cancer drug Erleada in new use, ... The FDA has approved Johnson & Johnson’s prostate cancer drug Erleada (apalutamide) for patients whose prostate cancer has spread.
News Astellas tests gamification ideas with Japanese universities Astellas has teamed up with Tokyo University of the Arts and Yokohama City University to create and commercialise new digital healthcare solutions using gamification.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
